no statement of use filed
on 19 Jun 2017
Last Applicant/ Owned by
PAUL-EHRLICH-STRASSE 15
TUEBINGEN
DE
72076
Serial Number
86374590 filed on 22nd Aug 2014
Registration Number
N/A
Correspondent Address
DAVID A. JACKSON
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
CHEMICAL REAGENTS AND BIOMOLECULES, IN PARTICULAR BIOLOGICAL MACROMOLECULES FOR INDUSTRY AND SCIENCE, REAGENTS FOR RESEARCH PURPOSES, ALL OF THE FOREGOING BEING GOODS WHICH TARGET OR WORK WITH RNA CHEMICAL PREPARATIONS FOR PHARMACEUTICAL OR MEDICAL PURPOSES, NAMELY, FOR THE TREATMENT OF NEUROLOGICAL, NEUROMUSCULAR, NEURODEGENERATIVE AND CARDIOVASCULAR DISEASES, FOR THE TREATMENT OF INFECTIOUS DISRead More
CHEMICAL REAGENTS AND BIOMOLECULES, IN PARTICULAR BIOLOGICAL MACROMOLECULES FOR INDUSTRY AND SCIENCE, REAGENTS FOR RESEARCH PURPOSES, ALL OF THE FOREGOING BEING GOODS WHICH TARGET OR WORK WITH RNA
CHEMICAL PREPARATIONS FOR PHARMACEUTICAL OR MEDICAL PURPOSES, NAMELY, FOR THE TREATMENT OF NEUROLOGICAL, NEUROMUSCULAR, NEURODEGENERATIVE AND CARDIOVASCULAR DISEASES, FOR THE TREATMENT OF INFECTIOUS DISEASES, AUTOIMMUNE DISEASES AND TUMOURS, FOR TREATMENT OF METABOLIC DISEASES AND FOR TREATMENT OF HERITABLE GENETIC DISEASES OR FOR THERAPIES REPLACING PROTEINS OR ENZYMES; PHARMACEUTICAL AND VETERNARY MEDICAL PREPARATIONS FOR THE TREATMENT OF NEUROLOGICAL, NEUROMUSCULAR, NEURODEGENERATIVE AND CARDIOVASCULAR DISEASES, FOR THE TREATMENT OF INFECTIOUS DISEASES, AUTOIMMUNE DISEASES AND TUMOURS, FOR TREATMENT OF METABOLIC DISEASES AND FOR TREATMENT OF HERITABLE GENETIC DISEASES OR FOR THERAPIES REPLACING PROTEINS OR ENZYMES; IMMUNOSTIMULATORY COMPOSITIONS; VACCINES, ADJUVANT IMMUNOSTIMULANTS; PHARMACEUTICALS AND MEDICAMENTS BASED ON/CONTAINING/PREPARED FROM BIOLOGICAL MACROMOLECULES FOR THE TREATMENT OF NEUROLOGICAL, NEUROMUSCULAR, NEURODEGENERATIVE AND CARDIOVASCULAR DISEASES, FOR THE TREATMENT OF INFECTIOUS DISEASES, AUTOIMMUNE DISEASES AND TUMOURS, FOR TREATMENT OF METABOLIC DISEASES AND FOR TREATMENT OF HERITABLE GENETIC DISEASES OR FOR THERAPIES REPLACING PROTEINS OR ENZYMES; GENE THERAPY PRODUCTS, NAMELY, NUCLEIC ACID MACROMOLECULES FOR IN VIVO EXPRESSION; FOOD SUPPLEMENTS FOR MEDICAL USE, ALL OF THE FOREGOING BEING GOODS WHICH TARGET OR WORK WITH RNA
MEDICAL AND VETERINARY SERVICES, IN PARTICULAR FOR THERAPEUTIC AND PROPHYLACTIC TREATMENT OF TUMOR DISEASES, INFECTIOUS DISEASES, AUTOIMMUNE DISEASES AND ALLERGIES, FOR THE TREATMENT OF HEREDITARY DISORDERS AND FOR PROTEIN OR ENZYME SUPPLEMENT THERAPY, FOR THE TREATMENT OF NEUROLOGICAL, NEUROMUSCULAR, NEURODEGENERATIVE AND CARDIOVASCULAR DISORDERS AND FOR THE TREATMENT OF ENDOCRINOLOGICAL DISORDERS
No 86374590
No Service Mark
No 2793-3-008
No
No
No
No
No
No
No
No
| Status Date | Action Taken |
|---|---|
| 19th Jun 2017 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED |
| 19th Jun 2017 | ABANDONMENT - NO USE STATEMENT FILED |
| 23rd Nov 2016 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| 04th Oct 2016 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 30th Sep 2016 | EXTENSION 1 FILED |
| 30th Sep 2016 | EXTENSION 1 GRANTED |
| 30th Sep 2016 | TEAS EXTENSION RECEIVED |
| 17th May 2016 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 22nd Mar 2016 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 22nd Mar 2016 | PUBLISHED FOR OPPOSITION |
